In fiscal year 2025, HYUNDAI BIOLAND (052260) reported revenue of 130.5 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 130.5 billion KRW | 12.7 billion KRW | 253 million KRW | [source] |
| 2024 | 119.5 billion KRW | 16.4 billion KRW | 5.7 billion KRW | [source] |
| 2023 | 101.7 billion KRW | 7.1 billion KRW | 8.1 billion KRW | [source] |
| 2022 | 99.2 billion KRW | 9.1 billion KRW | 4.8 billion KRW | [source] |
| 2021 | 102.8 billion KRW | 10.7 billion KRW | -11.7 billion KRW | [source] |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 165.7 billion KRW | 29.2 billion KRW | 136.5 billion KRW | [source] |
| 2024 | 180.9 billion KRW | 50.7 billion KRW | 130.2 billion KRW | [source] |
| 2023 | 167.6 billion KRW | 32.7 billion KRW | 134.9 billion KRW | [source] |
| 2022 | 162.5 billion KRW | 23.4 billion KRW | 139.1 billion KRW | [source] |
| 2021 | 151.8 billion KRW | 23.2 billion KRW | 128.5 billion KRW | [source] |
